{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:50:16Z","timestamp":1783648216680,"version":"3.55.0"},"reference-count":43,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Craniopharyngiomas are rare epithelial tumours arising along the path of the craniopharyngeal duct. Two major histological subtypes have been recognised, the papillary and the adamantinomatous. Craniopharyngiomas remain challenging tumours to manage and are associated with significant morbidities and mortality. Recent advances in the molecular pathology of these neoplasms have identified <ns4:italic>BRAF <\/ns4:italic>mutations in the papillary variant, offering promising options for targeted pharmacological treatment. The involvement of \u03b2-catenin and the Wnt pathway in the tumorigenesis of the adamantinomatous subtype has been previously established with the identification of stabilising mutations in exon 3 of <ns4:italic>CTNNB1<\/ns4:italic>. Further understanding of the pathogenesis of this subtype has been facilitated with the use of mouse models and xenograft experiments. It has been proposed that the clusters of cells with upregulated Wnt\/\u03b2-catenin signalling induce tumour formation in a paracrine manner; the complex interactions occurring between different cell populations need to be further clarified for further expansion of this hypothesis. This review outlines recent key advances in our understanding of the molecular pathology of craniopharyngiomas and discusses some of the challenges that need to be overcome for the development of targeted therapies that will hopefully improve the management and the outcomes of these patients.<\/ns4:p>","DOI":"10.12688\/f1000research.11549.1","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T09:55:05Z","timestamp":1500890105000},"page":"1202","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Recent advances in molecular pathology of craniopharyngioma"],"prefix":"10.12688","volume":"6","author":[{"given":"Sarah","family":"Larkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"291-7","DOI":"10.1017\/cjn.2015.301","article-title":"Sellar Masses: An Epidemiological Study.","volume":"43","author":"K Al-Dahmani","year":"2016","journal-title":"Can J Neurol Sci."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"755-63","DOI":"10.1007\/s11060-011-0540-6","article-title":"Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults.","volume":"104","author":"E Nielsen","year":"2011","journal-title":"J Neurooncol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"467-74","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.","volume":"100","author":"D Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1070-8","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.","volume":"14","author":"B Zacharia","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"371-97","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas.","volume":"27","author":"N Karavitaki","year":"2006","journal-title":"Endocr Rev."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"9-17","DOI":"10.1007\/s11102-012-0418-4","article-title":"Pathology and pathogenesis of craniopharyngiomas.","volume":"16","author":"S Larkin","year":"2013","journal-title":"Pituitary."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"219-28","DOI":"10.1007\/s40618-013-0050-9","article-title":"Management of craniopharyngiomas.","volume":"37","author":"N Karavitaki","year":"2014","journal-title":"J Endocrinol Invest."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"46-55","DOI":"10.1007\/s11102-012-0428-2","article-title":"Mortality and morbidity in adult craniopharyngioma.","volume":"16","author":"E Erfurth","year":"2013","journal-title":"Pituitary."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"1258-67","DOI":"10.1210\/jc.2011-2817","article-title":"Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients.","volume":"97","author":"A Gautier","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"397-409","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.","volume":"62","author":"N Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"267-81","DOI":"10.1007\/s11102-016-0751-0","article-title":"Risk-adapted, long-term management in childhood-onset craniopharyngioma.","volume":"20","author":"H M\u00fcller","year":"2017","journal-title":"Pituitary."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"1997-2001","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.","volume":"161","author":"S Sekine","year":"2002","journal-title":"Am J Pathol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"161-5","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.","volume":"46","author":"P Brastianos","year":"2014","journal-title":"Nat Genet."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"126-34","DOI":"10.1093\/jnen\/nlw116","article-title":"Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.","volume":"76","author":"T Goschzik","year":"2017","journal-title":"J Neuropathol Exp Neurol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.","volume":"4","author":"A H\u00f6lsken","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"927-9","DOI":"10.1007\/s00401-014-1270-6","article-title":"BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma.","volume":"127","author":"S Larkin","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"79-80","DOI":"10.1097\/PAT.0000000000000033","article-title":"BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas.","volume":"46","author":"M Farzin","year":"2014","journal-title":"Pathology."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"811-5","DOI":"10.1309\/AJCP37TLZLTUAOJL","article-title":"VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations.","volume":"141","author":"D Mordes","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"911-2","DOI":"10.1007\/s00401-013-1118-5","article-title":"VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation.","volume":"125","author":"J Sperveslage","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"1694-703","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.","volume":"367","author":"K Flaherty","year":"2012","journal-title":"N Engl J Med."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"544-6","DOI":"10.1007\/s11102-015-0663-4","article-title":"Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor.","volume":"19","author":"S Aylwin","year":"2016","journal-title":"Pituitary."},{"key":"ref-22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv310","article-title":"Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.","volume":"108","author":"P Brastianos","year":"2016","journal-title":"J Natl Cancer Inst."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-015-0211-5","article-title":"Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.","volume":"3","author":"J Gump","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"631-9","DOI":"10.1007\/s00401-010-0642-9","article-title":"Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.","volume":"119","author":"A H\u00f6lsken","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"4367-77","DOI":"10.1158\/1078-0432.CCR-10-2811","article-title":"EGFR signaling regulates tumor cell migration in craniopharyngiomas.","volume":"17","author":"A H\u00f6lsken","year":"2011","journal-title":"Clin Cancer Res."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"357-64","DOI":"10.1111\/j.1750-3639.2008.00180.x","article-title":"Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.","volume":"19","author":"A H\u00f6lsken","year":"2009","journal-title":"Brain Pathol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"256-64","DOI":"10.1093\/neuonc\/not195","article-title":"Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.","volume":"16","author":"C Stache","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"1-10","DOI":"10.1111\/bpa.12148","article-title":"Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model.","volume":"25","author":"C Stache","year":"2015","journal-title":"Brain Pathol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2016.8.FOCUS16307","article-title":"Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.","volume":"41","author":"J Apps","year":"2016","journal-title":"Neurosurg Focus."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"259-71","DOI":"10.1007\/s00401-012-0957-9","article-title":"Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.","volume":"124","author":"C Andoniadou","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"589-97","DOI":"10.1007\/s00401-005-1004-x","article-title":"Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.","volume":"109","author":"R Buslei","year":"2005","journal-title":"Acta Neuropathol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"732-6","DOI":"10.1309\/EALE-G7LD-6W71-67PX","article-title":"beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.","volume":"120","author":"A Hassanein","year":"2003","journal-title":"Am J Clin Pathol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1595-603","DOI":"10.1097\/01.pas.0000213328.64121.12","article-title":"Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach.","volume":"30","author":"B Hofmann","year":"2006","journal-title":"Am J Surg Pathol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"205-9","DOI":"10.1007\/s11060-004-5232-z","article-title":"Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.","volume":"73","author":"E Oikonomou","year":"2005","journal-title":"J Neurooncol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"1-8","DOI":"10.1007\/s12022-014-9341-8","article-title":"The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.","volume":"26","author":"V Preda","year":"2015","journal-title":"Endocr Pathol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"11482-7","DOI":"10.1073\/pnas.1101553108","article-title":"Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans.","volume":"108","author":"C Gaston-Massuet","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"433-45","DOI":"10.1016\/j.stem.2013.07.004","article-title":"Sox2(+) stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential.","volume":"13","author":"C Andoniadou","year":"2013","journal-title":"Cell Stem Cell."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"721-32","DOI":"10.1111\/nan.12226","article-title":"Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.","volume":"41","author":"J Martinez-Barbera","year":"2015","journal-title":"Neuropathol Appl Neurobiol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"T161-72","DOI":"10.1530\/JOE-15-0145","article-title":"60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.","volume":"226","author":"J Martinez-Barbera","year":"2015","journal-title":"J Endocrinol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"268-76","DOI":"10.1002\/stem.2267","article-title":"Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.","volume":"34","author":"J Martinez-Barbera","year":"2016","journal-title":"Stem Cells."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"546-56","DOI":"10.1007\/s11102-013-0543-8","article-title":"Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?","volume":"17","author":"A H\u00f6lsken","year":"2014","journal-title":"Pituitary."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"613-28","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.","volume":"168","author":"N McGranahan","year":"2017","journal-title":"Cell."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"50-6","DOI":"10.1007\/s11102-015-0682-1","article-title":"Histopathology and molecular characterisation of intrauterine-diagnosed congenital craniopharyngioma.","volume":"19","author":"V Scagliotti","year":"2016","journal-title":"Pituitary."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T17:00:23Z","timestamp":1553878823000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":43,"URL":"https:\/\/doi.org\/10.12688\/f1000research.11549.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.12475.r24346","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.12475.r24344","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.12475.r24344, Hermann M\u00fcller, Department of Pediatrics, Klinikum Oldenburg A\u00f6R, Medical Campus University Oldenburg, Oldenburg, Germany, 24 Jul 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1#referee-response-24344","order":0,"name":"referee-response-24344","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.12475.r24346, Juan Pedro Martinez-Barbera, Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, University College London, London, UK, 24 Jul 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-1202\/v1#referee-response-24346","order":1,"name":"referee-response-24346","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}